Metabolite screening of aromatic amine hair dyes using in vitro hepatic models

References

• Andrew AS, Schned AR, Heaney JA, Karagas MR. (2004). Bladder cancer risk and personal hair dye use. Int J Cancer 109(4):581–86.
   Google Scholar
• Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group. (2008). Carcinogenicity of some aromatic amines, organic dyes, and related exposures. Lancet Oncol 9(4):322–23.
   PubMedGoogle Scholar
• Block NL, Sigel MM, Lynne CM, Ng AB, Grosberg RA. (1978). The initiation, progress, and diagnosis of dog bladder cancer induced by 4-aminobiphenyl. Investig Urol 16(1):50–4.
   PubMedGoogle Scholar
• Butler MA, Guengerich FP, Kadlubar FF. (1989). Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome p-450 monooxygenases. Cancer Res 49:25–31.
   PubMed Web of Science ®Google Scholar
• Cheung YL, Snelling J, Mohammed NN, Gray TJ, Ioannides C. (1996). Interaction with the aromatic hydrocarbon receptor, CYP1A induction, and mutagenicity of a series of diaminotoluenes: implications for their carcinogenicity. Toxicol Appl Pharmacol 139(1):203–11.
   PubMedGoogle Scholar
• Ciotti M, Lakshmi VM, Basu N, Davis BB, Owens IS, Zenser TV. (1999). Glucuronidation of benzidine and its metabolites by cDNA- expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. Carcinogenesis 20(10):1963–9.
   PubMedGoogle Scholar
• Cohen SM, Boobis AR, Meek ME, Preston RJ, McGregor D. (2006). 4- Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans. Crit Rev Toxicol 36(10):803–19.
   PubMedGoogle Scholar
• de Graaf IAM, Van Meijeren CE, Pektaş F, Koster HJ. (2002). Comparison of in vitro preparations for semi-quantitative prediction of in vivo drug metabolism. Drug Metab Disposit 30(10):1129–36.
   PubMedGoogle Scholar
• Elsby R, Maggs JL, Ashby J, Park BK. (2001). Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J Pharmacol Exp Ther 297(1):103–13.
   PubMedGoogle Scholar
• Gago-Dominguez M, Bell DA, Watson MA, Yuan JM, Castelao JE, Hein DW, Chan KK, Coetzee GA, Ross RK, Yu MC. (2003). Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 24(3):483–9.
   PubMedGoogle Scholar
• Gago-Dominguez M, Castelao JE, Yuan J-M, Yu MC, Ross RK. (2001). Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 91:575–9.
   PubMed Web of Science ®Google Scholar
• Goebel C, Hewitt NJ, Kunze G, Wenker M, Hein DW, Beck H, Skare J. (2009). Skin metabolism of aminophenols: human keratinocytes as a suitable in vitro model to qualitatively predict the dermal transformation of 4-amino-2-hydroxytoluene in vivo. Toxicol Appl Pharmacol 235:114–23.
   PubMed Web of Science ®Google Scholar
• Green MD, Tephly T. (1987). N-glucuronidation of carcinogenic aromatic amines catalysed by rat hepatic microsomal preparations and purified rat liver uridine 5′-diphosphate-glucuronosyltransferases. Cancer Res 47(8):2028–31.
   PubMedGoogle Scholar
• Hammons GJ, Guengerich FP, Weis CC, Beland FA, Kadlubar FF. (1985). Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res 45(8):3578–85.
   PubMedGoogle Scholar
• Hedtke B, Gao Z, Chen LJ, Weber WM, Dix KJ. (2008). Metabolism and disposition of [14C]5-amino-o-cresol in female F344 rats and B6C3F1 mice. Xenobiotica 38(2):171–84.
   PubMedGoogle Scholar
• Hewitt NJ, Lechón MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschl G, Li AP, LeCluyse E, Groothuis GM, Hengstler JG. (2007). Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39(1):159–234.
   PubMed Web of Science ®Google Scholar
• Kato R, Kamataki T, Yamazoe Y. (1983). N-hydroxylation of carcinogenic and mutagenic aromatic amines. Environ Hlth Perspect 49:21–5.
   PubMed Web of Science ®Google Scholar
• Kim D, Guengerich FP. (2005). Cytochrome P450 activation of arylamines and heterocyclic amines. Ann Rev Pharmacol Toxicol 45:27–49.
   PubMed Web of Science ®Google Scholar
• Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, Silverman D. (2006). Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur J Cancer 42:1448–54.
   PubMed Web of Science ®Google Scholar
• Li AP, Hartman NR, Lu C, Collins JM, Strong JM. (1999). Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes. Br J Clin Pharmacol 48(5):733–42.
   PubMedGoogle Scholar
• Lin J, Dinney CP, Grossman HB, Wu X. (2006). Personal permanent hair dye use is not associated with bladder cancer risk: evidence from a case-control study. Cancer Epidemiol Biomark Prev 15:1746–9.
   PubMed Web of Science ®Google Scholar
• Nohynek GJ, Duche D, Garrigues A, Meunierm P-A, Toutain H, Leclaire J. (2005). Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicol Lett 158:196–212.
   PubMed Web of Science ®Google Scholar
• Poirier MC, Beland F. (1997). Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison. Mutat Res 376(1–2):177–84.
   PubMedGoogle Scholar
• Schut HA, Snyderwine EG. (1999). DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20(3):353–68.
   PubMedGoogle Scholar
• Stanley LA, Skare JA, Doyle E, Powrie R, D’Angelo D, Elcombe CR. (2005). Lack of evidence for metabolism of p-phenylenediamine by human hepatic cytochrome P450 enzymes. Toxicology 210(2–3):147–57.
   PubMedGoogle Scholar
• Testino SA, Patonay G. (2003). High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry. J Pharmaceut Biomed Anal 30(5):1459–67.
   PubMedGoogle Scholar
• Vineis P. (1994). Epidemiology of cancer from exposure to arylamines. Environ Hlth Perspect 102(6):7–10.
   PubMedGoogle Scholar
• Wise RW, Zenser TV, Kadlubar FF, Davis BB. (1984). Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res 44(5):1893–7.
   PubMedGoogle Scholar
• Yoshida M, Numoto S, Otsuka H. (1979). Histopathological changes induced in the urinary bladder and liver of female BALB/c mice treated simultaneously with 2-naphthylamine and cyclophosphamide. Gann 70(5):645–52.
   PubMedGoogle Scholar
• Zatar NA, Abu-Zuhri AZ, Abu-Shaweesh AA. (1998). Spectrophotometric determination of some aromatic amines. Talanta 47:883–90.
   PubMed Web of Science ®Google Scholar